OPKO Health to Collaborate with Bristol-Myers Squibb on Blood Test for Alzheimer's Disease Jan 10, 2011
OPKO Health Announces Publication on Technology Underlying Blood Test for Alzheimer's Disease Jan 6, 2011
OPKO Announces Restatement of Financial Statements to Properly Account for Series D Convertible Preferred Stock; No Impact on Cash, Revenues or Other Results from Operations Nov 9, 2010
